• Explore /
  • Poster
  • / Association of cabozantinib residual concentration (Ctrough) and blood clearance (Cl/F) with toxicity (tox) and progressive disease (PD) in metastatic renal cell carcinoma (mRCC) patients (pts): Results from a monocentric pharmacokinetics (PK) study.

Association of cabozantinib residual concentration (Ctrough) and blood clearance (Cl/F) with toxicity (tox) and progressive disease (PD) in metastatic renal cell carcinoma (mRCC) patients (pts): Results from a monocentric pharmacokinetics (PK) study.

Abstract Poster

Authors

null

Luigi Cerbone

Departement de Medicine Oncologique, Gustave Roussy, Villejuif, France

Luigi Cerbone , David Combarel , Stéphanie Foulon , Arthur Geraud , Carolina Alves , Emeline Colomba , Lucia Carril , Lisa Derosa , Ronan Flippot , Olivier Mir , Bernard Escudier , Angelo Paci , Laurence Albiges

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session: Renal Cell Cancer

Track

Renal Cell Cancer

Sub Track

Patient-Reported Outcomes and Real-World Evidence

Citation

J Clin Oncol 39, 2021 (suppl 6; abstr 292)

DOI

10.1200/JCO.2021.39.6_suppl.292

Abstract #

292

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters

Poster

2023 ASCO Genitourinary Cancers Symposium

Exposure toxicity and response relationship of cabozantinib (CABO) in patients with metastatic renal cell carcinoma (mRCC).

Exposure toxicity and response relationship of cabozantinib (CABO) in patients with metastatic renal cell carcinoma (mRCC).

First Author: Alexandre Xu-Vuillard

First Author: Alvise Mattana

First Author: Syed Arsalan Ahmed Naqvi

First Author: Umberto Basso